Single-ingredient formulation
Pejrox™
Etoricoxib 60 mg / 90 mg / 120 mg
Film-coated tablet · 10 × 10 tablets
View details
Fixed-dose combination
Cizmi-O™ Tablets
Cefixime 200 mg + Ofloxacin 200 mg
Cizmi-O™ is a fixed-dose combination tablet of cefixime 200 mg and ofloxacin 200 mg. Marketed by Shreemed Pharmaceutical Pvt. Ltd., Azadpur, Delhi.
Prices and availability are confirmed only by written quotation. We do not sell medicines online.
About Cizmi-O™
Cizmi-O™ is the brand under which Shreemed Pharmaceutical Pvt. Ltd. markets a fixed-dose combination of cefixime and ofloxacin. Each tablet contains cefixime 200 mg, an oral third-generation cephalosporin, and ofloxacin 200 mg, a fluoroquinolone antibacterial agent.
The two ingredients belong to different antibacterial classes and are combined in equal 200 mg strengths in a single tablet. Antibacterial medicines should be used only when prescribed by a registered medical practitioner.
Shreemed Pharmaceutical supplies its medicines to licensed chemists, hospitals and clinics, and through its retail counter, in accordance with the Drugs and Cosmetics Act, 1940 and the rules made under it.
Content on this website is for general information and is not medical advice. Consult a qualified healthcare professional before using any medicine. Prescription medicines are supplied only as permitted by law.
Pejrox™, Codfax™, Cizmi-O™, Daxria™, Zamta™ and Zamta Plus™ are brands of Shreemed Pharmaceutical Pvt. Ltd.
